+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bioidentical Hormones Market by Product Type, End User, Therapy Type, Delivery Method, Age Group, Gender - Global Forecast to 2030- Product Image
Bioidentical Hormones Market by Product Type, End User, Therapy Type, Delivery Method, Age Group, Gender - Global Forecast to 2030- Product Image
Sale

Bioidentical Hormones Market by Product Type, End User, Therapy Type, Delivery Method, Age Group, Gender - Global Forecast to 2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011384
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The bioidentical hormones market is undergoing rapid transformation as healthcare providers, patients, and pharmaceutical companies increasingly demand personalized approaches and robust supply chain strategies. Decision-makers are evaluating evolving technologies and shifting regulatory environments to secure consistent, high-quality therapeutic solutions.

Market Snapshot: Bioidentical Hormones Market Growth and Trends

The global bioidentical hormones market grew from USD 616.46 million in 2024 to USD 773.91 million in 2025. It is expected to continue expanding at a CAGR of 25.09%, reaching USD 2.36 billion by 2030. This segment, reflecting the broader shift toward individualized therapy and integrated wellness solutions, is increasingly shaped by healthcare provider preferences, patient education, and advanced compounding methods. Mature regions show high adoption rates driven by established distribution networks, while emerging markets incorporate modernization and specialty care investments for accelerated uptake. Digital health solutions further support patient adherence and therapy personalization.

Scope & Segmentation: Comprehensive Market Breakdown

  • Product Types: Creams, Gels, Sprays, Tablets
  • End Users: Clinics, Home Care, Hospitals, Retail Pharmacies
  • Therapy Types: Estrogen, Progesterone, Testosterone
  • Delivery Methods: Injectable (Injections), Oral (Capsules, Tablets), Topical (Creams, Gels, Sprays)
  • Age Groups: 18-49, 50-64, 65+
  • Gender Segmentation: Female, Male
  • Regions: Americas (United States including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, and others), Asia-Pacific (including China, India, Japan, Australia, and additional countries)
  • Key Company Coverage: Pfizer Inc., Bayer AG, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Novo Nordisk A/S, Viatris Inc., Endo International plc, AbbVie Inc., Allergan plc, Sun Pharmaceutical Industries Ltd.

Key Takeaways: Strategic Market Insights

  • Personalized medicine and digital integration are driving demand for tailored bioidentical hormone solutions, enhancing both patient outcomes and healthcare provider workflows.
  • Topical, oral, and injectable formulation options allow healthcare facilities and pharmacies to match patient preferences and clinical requirements, supporting broad adoption.
  • Compounding and automated dispensing technologies are strengthening precision and consistency, aligning with rising safety and compliance expectations in mature and developing markets alike.
  • Focused R&D, academic collaborations, and digital dosing platforms are enabling leading companies to optimize therapy effectiveness and respond to evolving consumer needs.
  • Regulatory harmonization efforts, especially in regions with variable standards, are helping stakeholders maintain product quality and market credibility.
  • Segment-specific adoption shows that topical applications are popular among younger age groups for their usability, while injectables are prioritized in clinical and hospital environments for precise dosing.

Tariff Impact: Market Resilience and Adaptive Strategies

A new wave of tariffs on pharmaceutical ingredients and finished products in 2025 has shifted cost structures and spurred manufacturers to diversify sourcing and pursue domestic supply partnerships. Companies are reevaluating procurement, with some absorbing increased expenses to maintain competitiveness, and others revising logistics strategies to control incremental costs. These changes have incentivized investment in local production, inventory optimization, and regulatory negotiations designed to streamline ingredient imports. Despite cost pressures, this period of supply chain recalibration is fostering greater industry agility and deeper collaboration across the value chain.

Methodology & Data Sources

This report leverages a rigorous combination of in-depth primary insights from industry professionals—including endocrinologists, pharmacists, and regulatory authorities—and secondary research from scientific, regulatory, and trade sources. Data triangulation, competitive mapping, and scenario analysis have been used to validate findings and synthesize actionable recommendations for stakeholders in the bioidentical hormones market.

Why This Report Matters

  • Enables strategic planning with actionable intelligence on regulatory change, patient trends, and technology adoption for senior leaders managing risk and opportunity.
  • Delivers nuanced segmentation and region-specific insights to reveal the most promising growth pockets and operational strategies in a complex, evolving market.
  • Equips executives to anticipate future developments, supporting investment in supply chain resilience, digital health engagement, and compliance best practices.

Conclusion

The bioidentical hormones market continues to advance as technology, patient expectations, and regulatory considerations reshape therapeutic models and competitive positioning. Informed strategies and responsive leadership will be essential to sustain growth and deliver consistent value in this dynamic sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bioidentical Hormones Market, by Product Type
8.1. Introduction
8.2. Creams
8.3. Gels
8.4. Sprays
8.5. Tablets
9. Bioidentical Hormones Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Home Care
9.4. Hospitals
9.5. Retail Pharmacies
10. Bioidentical Hormones Market, by Therapy Type
10.1. Introduction
10.2. Estrogen
10.3. Progesterone
10.4. Testosterone
11. Bioidentical Hormones Market, by Delivery Method
11.1. Introduction
11.2. Injectable
11.2.1. Injections
11.3. Oral
11.3.1. Capsules
11.3.2. Tablets
11.4. Topical
11.4.1. Creams
11.4.2. Gels
11.4.3. Sprays
12. Bioidentical Hormones Market, by Age Group
12.1. Introduction
12.2. 18-49
12.3. 50-64
12.4. 65+
13. Bioidentical Hormones Market, by Gender
13.1. Introduction
13.2. Female
13.3. Male
14. Americas Bioidentical Hormones Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Bioidentical Hormones Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Bioidentical Hormones Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Pfizer Inc.
17.3.2. Bayer AG
17.3.3. Merck & Co., Inc.
17.3.4. Teva Pharmaceutical Industries Ltd.
17.3.5. Novo Nordisk A/S
17.3.6. Viatris Inc.
17.3.7. Endo International plc
17.3.8. AbbVie Inc.
17.3.9. Allergan plc
17.3.10. Sun Pharmaceutical Industries Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BIOIDENTICAL HORMONES MARKET MULTI-CURRENCY
FIGURE 2. BIOIDENTICAL HORMONES MARKET MULTI-LANGUAGE
FIGURE 3. BIOIDENTICAL HORMONES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BIOIDENTICAL HORMONES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BIOIDENTICAL HORMONES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOIDENTICAL HORMONES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY SPRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY ESTROGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY PROGESTERONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY TESTOSTERONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY SPRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY 18-49, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY 50-64, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY 65+, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 60. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 61. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 63. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 64. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 65. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 66. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 67. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 68. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 69. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 72. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 73. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 74. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 75. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 76. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 77. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 115. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 118. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 119. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 120. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 121. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 122. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 123. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 124. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 127. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 128. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 129. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 130. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 131. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 132. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 133. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 139. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 140. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 142. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 145. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 146. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 147. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 148. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 149. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 150. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 151. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 154. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 155. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 156. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 157. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 158. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 159. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 160. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 161. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 167. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 168. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 174. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 176. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 178. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 186. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 187. DENMARK BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. DENMARK BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. DENMARK BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 190. DENMARK BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 191. DENMARK BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 192. DENMARK BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 193. DENMARK BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 194. DENMARK BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 195. DENMARK BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 205. QATAR BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 206. QATAR BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. QATAR BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 208. QATAR BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 209. QATAR BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 210. QATAR BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 211. QATAR BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 212. QATAR BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 213. QATAR BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 214. FINLAND BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 215. FINLAND BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. FINLAND BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 217. FINLAND BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 218. FINLAND BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 219. FINLAND BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 220. FINLAND BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 221. FINLAND BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 222. FINLAND BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 223. SWEDEN BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. SWEDEN BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. SWEDEN BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 226. SWEDEN BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 227. SWEDEN BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 230. SWEDEN BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 231. SWEDEN BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 232. NIGERIA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 241. EGYPT BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 242. EGYPT BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. EGYPT BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 244. EGYPT BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 245. EGYPT BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 246. EGYPT BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 247. EGYPT BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 248. EGYPT BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 249. EGYPT BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 250. TURKEY BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 251. TURKEY BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. TURKEY BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 253. TURKEY BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 254. TURKEY BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 255. TURKEY BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 256. TURKEY BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 257. TURKEY BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 258. TURKEY BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 259. ISRAEL BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 260. ISRAEL BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. ISRAEL BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 262. ISRAEL BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 263. ISRAEL BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 266. ISRAEL BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 268. NORWAY BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. NORWAY BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. NORWAY BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 271. NORWAY BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 272. NORWAY BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 273. NORWAY BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 274. NORWAY BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 275. NORWAY BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 276. NORWAY BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 277. POLAND BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 278. POLAND BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. POLAND BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 280. POLAND BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 281. POLAND BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 282. POLAND BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 283. POLAND BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 284. POLAND BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 285. POLAND BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 286. SWITZERLAND BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 287. SWITZERLAND BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. SWITZERLAND BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 289. SWITZERLAND BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 290. SWITZERLAND BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 291. SWITZERLAND BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 292. SWITZERLAND BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 293. SWITZERLAND BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 294. SWITZERLAND BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 295. ASIA-PACIFIC BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 296. ASIA-PACIFIC BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 297. ASIA-PACIFIC BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 298. ASIA-PACIFIC BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 305. CHINA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 306. CHINA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 307. CHINA BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 308. CHINA BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 309. CHINA BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 310. CHINA BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 311. CHINA BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 312. CHINA BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 313. CHINA BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 314. INDIA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 315. INDIA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 316. INDIA BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 317. INDIA BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 318. INDIA BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 319. INDIA BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 320. INDIA BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 321. INDIA BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 322. INDIA BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 323. JAPAN BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 324. JAPAN BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 325. JAPAN BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 326. JAPAN BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 327. JAPAN BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 328. JAPAN BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 329. JAPAN BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 330. JAPAN BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 331. JAPAN BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 332. AUSTRALIA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 333. AUSTRALIA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 334. AUSTRALIA BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 335. AUSTRALIA BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 336. AUSTRALIA BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 337. AUSTRALIA BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 338. AUSTRALIA BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 339. AUSTRALIA BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 340. AUSTRALIA BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 341. SOUTH KOREA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 342. SOUTH KOREA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 343. SOUTH KOREA BIOIDENTICAL HORMONES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 344. SOUTH KOREA BIOIDENTICAL HORMONES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 345. SOUTH KOREA BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 346. SOUTH KOREA BIOIDENTICAL HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 347. SOUTH KOREA BIOIDENTICAL HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 348. SOUTH KOREA BIOIDENTICAL HORMONES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 349. SOUTH KOREA BIOIDENTICAL HORMONES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 350. INDONESIA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODU

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Bioidentical Hormones market report include:
  • Pfizer Inc.
  • Bayer AG
  • Merck & Co., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Novo Nordisk A/S
  • Viatris Inc.
  • Endo International plc
  • AbbVie Inc.
  • Allergan plc
  • Sun Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages199
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 773.91 Million
Forecasted Market Value ( USD ) by 2030 $ 2360 Million
Compound Annual Growth Rate25.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Bioidentical Hormones Market Report 2025 - Product Image

Bioidentical Hormones Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Synthetic Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Synthetic Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Synthetic Hormones Market by Hormone Class, Application, Technology, End User - Global Forecast to 2030 - Product Image

Synthetic Hormones Market by Hormone Class, Application, Technology, End User - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Human Growth Hormone Market by Application, Type, End User, Distribution Channel, Dosage Form - Global Forecast to 2030 - Product Image

Human Growth Hormone Market by Application, Type, End User, Distribution Channel, Dosage Form - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global
From
Human Growth Hormone (HGH) - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Human Growth Hormone (HGH) - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From

About the Bioidentical Hormones Market

Bioidentical hormones are biotechnological products that are chemically identical to hormones naturally produced by the human body. They are used to treat a variety of medical conditions, including menopause, andropause, and hormone imbalances. Bioidentical hormones are typically derived from plant sources, such as yams and soybeans, and are then synthesized in a laboratory to create a product that is identical to the hormones produced by the body. Bioidentical hormones are becoming increasingly popular due to their ability to provide relief from symptoms associated with hormone imbalances without the side effects associated with traditional hormone replacement therapies. They are also seen as a more natural alternative to synthetic hormones. The bioidentical hormones market is growing rapidly, driven by increasing awareness of the benefits of bioidentical hormones and the availability of more affordable products. The market is expected to continue to grow in the coming years as more people become aware of the potential benefits of bioidentical hormones. Some companies in the bioidentical hormones market include BioTE Medical, BHRT Solutions, and Compounding Solutions. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.